News
29.07.2025
GBAICTI, Bay Trial and Immuno Cure Signed Tripartite MOU to Strengthen GBA Clinical Research Collaboration
Greater Bay Area International Clinical Trial Institute, Greater Bay Area International Clinical Trials Center of Shenzhen and Immuno Cure BioTech signed a tripartite Memorandum of Understanding on July 29, 2025.
29.07.2025
GBAICTI and Bay Trial Signed a MOU to Strengthen Clinical Research Collaboration
GBAICTI and Bay Trial signed a Memorandum of Understanding on July 29, 2025 to strengthen collaboration between Shenzhen and Hong Kong in the field of clinical research.
09.07.2025
GBAICTI and Hong Kong Genome Institute Explore Partnership in Genomic Medicine
Greater Bay Area International Clinical Trial Institute (GBAICTI) met with Hong Kong Genome Institute (HKGI) to explore collaborative opportunities in genomic medicine.
26.06.2025
Delegation Visit of NMPA GBA Center
On June 26, 2025, a delegation from the GBA Center for Medical Device Evaluation and Inspection of the National Medical Products Administration (NMPA) visited GBAICTI to learn about the its facility, ongoing work, and future development plans.
21.05.2025
GBAICTI signed MOU on clinical trial collaboration with HKU and CUHK medical faculties
Greater Bay Area International Clinical Trial Institute held a collaboration meeting with the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) and the Faculty of Medicine of the Chinese University of Hong Kong (CU Medicine) to have an in-depth exchange on advancing clinical trial collaboration on May 21, 2025. The three parties signed a Memorandum of Understanding (MOU) on clinical trial collaboration after the meeting.
23.02.2025
GBAICTI Shared Vision at Hong Kong Pharmacy Conference 2025
Greater Bay Area International Clinical Trial Institute was featured at the Hong Kong Pharmacy Conference 2025, where Professor Bernard Cheung, CEO of GBAICTI, delivered a theme speech on enhancing clinical trial capacity in the region.